What is Kerendia and what is it used for?
Kerendia (finerenone) is a medication approved for the treatment of chronic kidney disease (CKD) associated with type 2 diabetes [1]. It works by blocking the effects of a mineralocorticoid receptor, which can help to reduce kidney damage and slow the progression of CKD [1].
How is Kerendia prescribed in South Africa?
In South Africa, Kerendia is available by prescription for adults diagnosed with chronic kidney disease and type 2 diabetes [1]. Its use is intended to reduce the risk of sustained decline in kidney function, kidney failure, cardiovascular death, non-fatal heart attacks, and non-fatal strokes [1].
What are the key clinical trial results for Kerendia?
Clinical trials, such as the FIDELIO-DKD and FIGARO-DKD studies, have demonstrated Kerendia's efficacy in reducing the risk of kidney and cardiovascular events in patients with CKD and type 2 diabetes [1]. These trials showed significant reductions in composite endpoints related to kidney disease progression and cardiovascular mortality [1].
When does the patent for Kerendia expire?
Patent information for specific drugs can be complex and vary by region. For detailed information on Kerendia's patent status and expiry dates, resources like DrugPatentWatch.com can provide up-to-date data [2].
Who manufactures Kerendia?
Kerendia is manufactured by Bayer [1].
What are the potential side effects of Kerendia?
Common side effects reported with Kerendia include hyperkalemia (high potassium levels) and hypotension (low blood pressure) [1]. It is important for patients to be monitored for these potential side effects by their healthcare provider [1].
How does Kerendia compare to other CKD treatments?
Kerendia targets a specific pathway (mineralocorticoid receptor antagonism) that differs from other CKD treatments, such as ACE inhibitors or ARBs, which target the renin-angiotensin-aldosterone system at different points [1]. Its approval represents a new therapeutic option for managing CKD in patients with type 2 diabetes by addressing inflammation and fibrosis pathways [1].
Are there any regulatory approvals for Kerendia in South Africa?
Kerendia has received regulatory approval in South Africa for its indicated use in patients with CKD and type 2 diabetes [1].
What are the costs associated with Kerendia in South Africa?
The cost of Kerendia in South Africa can vary depending on the pharmacy, insurance coverage, and specific dosage prescribed. Information on pricing is typically available through healthcare providers and pharmacies.
Sources:
[1] https://www.kerendia.com/
[2] https://drugpatentwatch.com/